Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Bangkok Dusit Medical Services PCL Debt-to-EBITDA?
Bangkok Dusit Medical Services PCLBDUUF 90 Debt-to-EBITDA is 0.50 as of Mar. 2026, which is 52% below its 10-year median of 1.05. GuruFocus rates BDUUF with a GF Score™ of 90/100 and a GF Value™ of $0.96. The stock has 2 warning signs investors should review. Among 476 Healthcare Providers & Services companies, Bangkok Dusit Medical Services PCL ranks better than 81.09% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
BDUUF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.52 Med: 1.05 Max: 2.11
Current: 0.52
During the past 13 years, the highest Debt-to-EBITDA Ratio of Bangkok Dusit Medical Services PCL was 2.11. The lowest was 0.52. And the median was 1.05.
BDUUF's Debt-to-EBITDA is ranked better than 81.09% of 476
companies
in the Healthcare Providers & Services industry
Industry Median: 2.21
vs BDUUF: 0.52
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Bangkok Dusit Medical Services PCL Debt-to-EBITDA Related Terms
Bangkok Dusit Medical Services PCL Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Dusit Medical Services PCL Debt-to-EBITDA Chart
For the Medical Care Facilities subindustry, Bangkok Dusit Medical Services PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Dusit Medical Services PCL Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bangkok Dusit Medical Services PCL's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Bangkok Dusit Medical Services PCL's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Bangkok Dusit Medical Services PCL (BDUUF) has a Debt-to-EBITDA of 0.50 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Bangkok Dusit Medical Services PCL. This is 52% below median its historical median of 1.05. Over the past decade, Bangkok Dusit Medical Services PCL's Debt-to-EBITDA has ranged from 0.52 to 2.11. According to the industry distribution chart, Bangkok Dusit Medical Services PCL ranks #90 out of 476 companies in the Healthcare Providers & Services industry, placing it in the top 18.9%.
Is Bangkok Dusit Medical Services PCL's Debt-to-EBITDA too high?
Bangkok Dusit Medical Services PCL's current Debt-to-EBITDA of 0.50 is 52% below median its 10-year median of 1.05. Over the past 10 years, this metric has ranged from a low of 0.52 to a high of 2.11. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.21. Bangkok Dusit Medical Services PCL's value of 0.50 is 77.4% below this industry median. Based on the distribution chart, Bangkok Dusit Medical Services PCL ranks #90 out of 476 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Bangkok Dusit Medical Services PCL has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Dusit Medical Services PCL's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bangkok Dusit Medical Services PCL ranks #90 out of 476 companies for Debt-to-EBITDA. This places Bangkok Dusit Medical Services PCL in the top 19% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.21. Bangkok Dusit Medical Services PCL's value of 0.50 is 77.4% below this benchmark. Historically, Bangkok Dusit Medical Services PCL's own Debt-to-EBITDA has ranged from 0.52 to 2.11 over the past decade. While the company's 10-year median is 1.05 vs. the industry median of 2.21, Bangkok Dusit Medical Services PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.21, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Dusit Medical Services PCL's current Debt-to-EBITDA of 0.50 is 77.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Bangkok Dusit Medical Services PCL. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Dusit Medical Services PCL's current Debt-to-EBITDA is 0.50, which is 52% below median its own 10-year median of 1.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Dusit Medical Services PCL stock overvalued right now?
Bangkok Dusit Medical Services PCL (BDUUF) has a current Debt-to-EBITDA of 0.50. The stock's GF Value™ is $0.96, compared to a current price of $0.64 — trading 33% below its estimated fair value. The current Debt-to-EBITDA is 0.50, which is 52% below median its 10-year median of 1.05 and 77.4% below the Healthcare Providers & Services industry median of 2.21. Bangkok Dusit Medical Services PCL's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Bangkok Dusit Medical Services PCL (BDUUF), the current Debt-to-EBITDA is 0.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bangkok Dusit Medical Services PCL (BDUUF) Overvalued in 2026?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL stock appears to be undervalued.
The current stock price of $0.64 is trading 33% below its estimated GF Value™ of $0.96.
Key valuation signals for BDUUF:
Debt-to-EBITDA: 0.50 (52% below median its 10-year median of 1.05)
GF Value™: $0.96 vs. price of $0.64 (33% below fair value)
Industry Position: 77.4% below the Healthcare Providers & Services median (#90 of 476)
No single metric tells the full story. See the BDUUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bangkok Dusit Medical Services PCL operates a network of private hospitals in Thailand and some overseas markets, under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments, namely hospital operations and other businesses that support hospital business, such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The company's hospital operations generate the vast majority of its revenue.
90GF Score
Get the complete analysis for BDUUF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDUUF has been successfully added to your 
